Welcome drinks and refreshments

Introduction: Thomas Wilke, Co-founder and Scientific Director at GIPAM, will be addressing key questions in the following presentations.

• How will JCA change the HTA and payor assessment landscape?

• Which processes/steps need pharma companies to take into account, how will JCA preparations be organized internally?

• Will JCA change the assessment methodology of national HTA bodies?

• Will innovative reimbursement solutions such as P4P be more probable/less probable with JCA?

• Necessary internal preparations & challenges

• Perspective of Italian HTA body and payors

• Perspective of an innovative company, with a focus on oncology

• Perspective from a GER HTA/payor viewpoint

Enjoy refreshments and networking opportunities!